These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Pre-ataxic loss of intrinsic plasticity and motor learning in a mouse model of SCA1. Osório C, White JJ, Lu H, Beekhof GC, Fiocchi FR, Andriessen CA, Dijkhuizen S, Post L, Schonewille M. Brain; 2023 Jun 01; 146(6):2332-2345. PubMed ID: 36352508 [Abstract] [Full Text] [Related]
4. Progressive impairment of cerebellar mGluR signalling and its therapeutic potential for cerebellar ataxia in spinocerebellar ataxia type 1 model mice. Shuvaev AN, Hosoi N, Sato Y, Yanagihara D, Hirai H. J Physiol; 2017 Jan 01; 595(1):141-164. PubMed ID: 27440721 [Abstract] [Full Text] [Related]
5. Inhibition of colony-stimulating factor 1 receptor early in disease ameliorates motor deficits in SCA1 mice. Qu W, Johnson A, Kim JH, Lukowicz A, Svedberg D, Cvetanovic M. J Neuroinflammation; 2017 May 25; 14(1):107. PubMed ID: 28545543 [Abstract] [Full Text] [Related]
6. Post-symptomatic Delivery of Brain-Derived Neurotrophic Factor (BDNF) Ameliorates Spinocerebellar Ataxia Type 1 (SCA1) Pathogenesis. Sheeler C, Rosa JG, Borgenheimer E, Mellesmoen A, Rainwater O, Cvetanovic M. Cerebellum; 2021 Jun 25; 20(3):420-429. PubMed ID: 33394333 [Abstract] [Full Text] [Related]
7. Pharmacological enhancement of mGlu1 metabotropic glutamate receptors causes a prolonged symptomatic benefit in a mouse model of spinocerebellar ataxia type 1. Notartomaso S, Zappulla C, Biagioni F, Cannella M, Bucci D, Mascio G, Scarselli P, Fazio F, Weisz F, Lionetto L, Simmaco M, Gradini R, Battaglia G, Signore M, Puliti A, Nicoletti F. Mol Brain; 2013 Nov 19; 6():48. PubMed ID: 24252411 [Abstract] [Full Text] [Related]
8. Assessing the efficacy of specific cerebellomodulatory drugs for use as therapy for spinocerebellar ataxia type 1. Nag N, Tarlac V, Storey E. Cerebellum; 2013 Feb 19; 12(1):74-82. PubMed ID: 22718440 [Abstract] [Full Text] [Related]
9. Treadmill training increases the motor activity and neuron survival of the cerebellum in a mouse model of spinocerebellar ataxia type 1. Chuang CS, Chang JC, Soong BW, Chuang SF, Lin TT, Cheng WL, Orr HT, Liu CS. Kaohsiung J Med Sci; 2019 Nov 19; 35(11):679-685. PubMed ID: 31271500 [Abstract] [Full Text] [Related]
10. Deranged calcium signaling in Purkinje cells and pathogenesis in spinocerebellar ataxia 2 (SCA2) and other ataxias. Kasumu A, Bezprozvanny I. Cerebellum; 2012 Sep 19; 11(3):630-9. PubMed ID: 20480274 [Abstract] [Full Text] [Related]
11. Purkinje cell COX deficiency and mtDNA depletion in an animal model of spinocerebellar ataxia type 1. Ripolone M, Lucchini V, Ronchi D, Fagiolari G, Bordoni A, Fortunato F, Mondello S, Bonato S, Meregalli M, Torrente Y, Corti S, Comi GP, Moggio M, Sciacco M. J Neurosci Res; 2018 Sep 19; 96(9):1576-1585. PubMed ID: 30113722 [Abstract] [Full Text] [Related]
12. Intranasal administration of IGF-I improves behavior and Purkinje cell pathology in SCA1 mice. Vig PJ, Subramony SH, D'Souza DR, Wei J, Lopez ME. Brain Res Bull; 2006 May 15; 69(5):573-9. PubMed ID: 16647585 [Abstract] [Full Text] [Related]
13. Transient cerebellar alterations during development prior to obvious motor phenotype in a mouse model of spinocerebellar ataxia type 6. Jayabal S, Ljungberg L, Watt AJ. J Physiol; 2017 Feb 01; 595(3):949-966. PubMed ID: 27531396 [Abstract] [Full Text] [Related]
14. Short-term succinic acid treatment mitigates cerebellar mitochondrial OXPHOS dysfunction, neurodegeneration and ataxia in a Purkinje-specific spinocerebellar ataxia type 1 (SCA1) mouse model. Ferro A, Carbone E, Zhang J, Marzouk E, Villegas M, Siegel A, Nguyen D, Possidente T, Hartman J, Polley K, Ingram MA, Berry G, Reynolds TH, Possidente B, Frederick K, Ives S, Lagalwar S. PLoS One; 2017 Feb 01; 12(12):e0188425. PubMed ID: 29211771 [Abstract] [Full Text] [Related]
15. In vivo monitoring of recovery from neurodegeneration in conditional transgenic SCA1 mice. Oz G, Vollmers ML, Nelson CD, Shanley R, Eberly LE, Orr HT, Clark HB. Exp Neurol; 2011 Dec 01; 232(2):290-8. PubMed ID: 21963649 [Abstract] [Full Text] [Related]
16. Computational analysis of calcium signaling and membrane electrophysiology in cerebellar Purkinje neurons associated with ataxia. Brown SA, Loew LM. BMC Syst Biol; 2012 Jun 15; 6():70. PubMed ID: 22703638 [Abstract] [Full Text] [Related]
17. In vivo analysis of the spontaneous firing of cerebellar Purkinje cells in awake transgenic mice that model spinocerebellar ataxia type 2. Egorova PA, Gavrilova AV, Bezprozvanny IB. Cell Calcium; 2021 Jan 15; 93():102319. PubMed ID: 33248384 [Abstract] [Full Text] [Related]
19. Memantine suppresses the excitotoxicity but fails to rescue the ataxic phenotype in SCA1 model mice. Belozor OS, Vasilev A, Mileiko AG, Mosina LD, Mikhailov IG, Ox DA, Boitsova EB, Shuvaev AN, Teschemacher AG, Kasparov S, Shuvaev AN. Biomed Pharmacother; 2024 May 15; 174():116526. PubMed ID: 38574621 [Abstract] [Full Text] [Related]
20. Altered synaptic and firing properties of cerebellar Purkinje cells in a mouse model of ARSACS. Ady V, Toscano-Márquez B, Nath M, Chang PK, Hui J, Cook A, Charron F, Larivière R, Brais B, McKinney RA, Watt AJ. J Physiol; 2018 Sep 15; 596(17):4253-4267. PubMed ID: 29928778 [Abstract] [Full Text] [Related] Page: [Next] [New Search]